These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7177635)
1. [Possibilities and limits of polychemotherapy in hematology]. István L Orv Hetil; 1982 Nov; 123(47):2879-85. PubMed ID: 7177635 [No Abstract] [Full Text] [Related]
2. [New chemotherapeutics in hematology]. Klener P Vnitr Lek; 1971 Mar; 17(3):249-54. PubMed ID: 5574568 [No Abstract] [Full Text] [Related]
3. [Antibody therapy in hematology and oncology--2]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594 [No Abstract] [Full Text] [Related]
4. [Achievements in the treatment of leukemia and lymphoma]. Berchenal J Klin Med (Mosk); 1973 Jun; 51(6):15-20. PubMed ID: 4590258 [No Abstract] [Full Text] [Related]
5. [Results of polychemotherapy of patients with non-Hodgkin's lymphoma]. Varga G; Krizsa F; Vezendi K; Kálmán A; Cserháti I Orv Hetil; 1980 Jul; 121(28):1697-700. PubMed ID: 7005810 [No Abstract] [Full Text] [Related]
6. Leukaemia and lymphoma: the prospect of control. Hayhoe FG Schweiz Med Wochenschr; 1974 Dec; 104(51):1897-907. PubMed ID: 4612705 [No Abstract] [Full Text] [Related]
8. [Polychemotherapy in refractory leukemias of the adult]. Bruntsch U; Osieka R; Gallmeier WM; Seeber S; Schmidt CG Verh Dtsch Ges Inn Med; 1975; 81():1121-3. PubMed ID: 1229413 [No Abstract] [Full Text] [Related]
9. [2 polychemotherapy regimens in generalized non-Hodgkin's lymphomas, classified according to the Kiel system. A retrospective analysis]. From J; Teglbjerg PS; Brincker H Ugeskr Laeger; 1981 Oct; 143(42):2740-4. PubMed ID: 7324216 [No Abstract] [Full Text] [Related]
10. [Chemotherapy of non-hodgkin's lymphomas (author's transl)]. Fereberger W; Neubauer M Acta Med Austriaca; 1981; 8(1):1-6. PubMed ID: 7234308 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities in the treatment of advanced malignant lymphoma insensitive to the usual combination of cytostatics]. Klener P; Donner L; Ort J Vnitr Lek; 1976 Aug; 22(8):760-6. PubMed ID: 61642 [No Abstract] [Full Text] [Related]
13. Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas. Tallman MS Semin Hematol; 2008 Jul; 45(3 Suppl 2):S1. PubMed ID: 18760703 [No Abstract] [Full Text] [Related]
14. [Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations]. Hanauske AR Med Klin (Munich); 1996 Apr; 91 Suppl 3():68-70. PubMed ID: 8692122 [No Abstract] [Full Text] [Related]
15. [Chemotherapy in lymphoproliferative syndromes]. Berumen LJ Rev Med Hosp Gen (Mex); 1965 Apr; 28(4):287-97. PubMed ID: 5838577 [No Abstract] [Full Text] [Related]
16. [Disseminated intravascular coagulation after polychemotherapy of proliferative hematologic diseases]. Kaczmarek M Pediatr Pol; 1981 Sep; 56(9):1031-7. PubMed ID: 6948266 [No Abstract] [Full Text] [Related]
17. [The treatment of chronic hemoblastosis with new cytostatic agents]. Quattrin N Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017 [No Abstract] [Full Text] [Related]
18. [Drugs needed for treatment of patients with hemoblastosis]. Lebedev VN; Sarkisian SP Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):45-8. PubMed ID: 877053 [No Abstract] [Full Text] [Related]
19. Developments in the treatment of leukaemias and lymphomas. Ann Hematol; 1995 Jun; 68(3 Suppl):1-8. PubMed ID: 7619921 [No Abstract] [Full Text] [Related]
20. [Advances in drug therapy of neoplasms]. Gross R Verh Dtsch Ges Inn Med; 1972; 78():93-105. PubMed ID: 4665784 [No Abstract] [Full Text] [Related] [Next] [New Search]